GlassScriptPhysician profile
Joseph S Healy
NPI 1194899484
$1,206.64
in general payments reported to CMS, 2019-2025
17 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $44.23 · 2021: $52.61 · 2022: $32.08 · 2023: $114 · 2024: $240 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $603.17 | 2019-2025 | |
| Enterra Medical, INC. | $135.80 | 2025 | |
| Boston Scientific Corporation | $59.03 | 2019-2021 | |
| Ucb, INC. | $51.00 | 2019 | |
| Pentax of America, INC. | $48.27 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.74 | 2019 | |
| Janssen Biotech, INC. | $44.19 | 2019-2025 | Tremfya |
| Biogen, INC. | $38.78 | 2024-2025 | Leqembi |
| Janssen Pharmaceuticals, INC | $38.09 | 2024-2025 | Spravato |
| Pfizer INC. | $36.93 | 2019 | |
| Ardelyx, INC. | $20.84 | 2024 | Ibsrela |
| Novo Nordisk INC | $17.78 | 2024 | Ozempic, Rybelsus |
| Braintree Laboratories, INC. | $16.98 | 2023 | Sutab, Suflave |
| Medtronic, INC. | $13.48 | 2024 | Interstim |
| Allergan, INC. | $12.99 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $12.49 | 2019 | |
| Merck Sharp & Dohme LLC | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.